Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial. (Record no. 22553322)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02366 a2200613 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516140110.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201305s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1527-7755 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1200/JCO.2012.46.3299 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Martins, Renato G |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20130531 |
| 245 00 - TITLE STATEMENT | |
| Title | Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
| Date of publication, distribution, etc. | Apr 2013 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1415-21 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma, Squamous Cell |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chemoradiotherapy |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cisplatin |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Administration Schedule |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | ErbB Receptors |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Erlotinib Hydrochloride |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Exanthema |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Head and Neck Neoplasms |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | In Situ Hybridization, Fluorescence |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pain |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Quinazolines |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Remission Induction |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Parvathaneni, Upendra |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bauman, Julie E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sharma, Anand K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Raez, Luis E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Papagikos, Michael A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yunus, Furhan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kurland, Brenda F |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Eaton, Keith D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liao, Jay J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mendez, Eduardo |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Futran, Neal |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wang, David X |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chai, Xiaoyu |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wallace, Sarah G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Austin, Melissa |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schmidt, Rodney |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hayes, D Neil |
| 773 0# - HOST ITEM ENTRY | |
| Title | Journal of clinical oncology : official journal of the American Society of Clinical Oncology |
| Related parts | vol. 31 |
| -- | no. 11 |
| -- | p. 1415-21 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1200/JCO.2012.46.3299">https://doi.org/10.1200/JCO.2012.46.3299</a> |
| Public note | Available from publisher's website |
No items available.